“Liquid biopsies” could track diffuse midline gliomas | Children's National

“Liquid biopsies” could track diffuse midline gliomas | Children's National

“Liquid biopsies” could track diffuse midline gliomas A multi-institutional team led by researchers at Children’s National showed that quantifying the amount of circulating tumor DNA possessing key mutations characteristic of diffuse midline gliomas could reliably predict the tumors’ response to radiotherapy.